ID   CT66
AC   CVCL_KR84
SY   CT 66; CT-66
DR   Wikidata; Q54814726
RX   Patent=US5459043;
RX   PubMed=8504532;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10218.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI:62265; Beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc (Lewis A).
CC   Monoclonal antibody target: ChEBI; CHEBI:61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
RX   Patent=US5459043;
RA   Brown J.P.;
RT   "Hybridoma CT43 producing a monoclonal antibody to a novel mucin
RT   epitope which correlates with the presence of colorectal cancer.";
RL   Patent number US5459043, 17-Oct-1995.
//
RX   PubMed=8504532; DOI=10.1093/clinchem/39.6.1029;
RA   van Kamp G.J., von Mensdorff-Pouilly S., Kenemans P., Verstraeten R.,
RA   Yedema C.A., Wobbes T., Bon G.G., Kok A., Brown J.P., Hilgers J.,
RA   Meyer S.;
RT   "Evaluation of colorectal cancer-associated mucin CA M43 assay in
RT   serum.";
RL   Clin. Chem. 39:1029-1032(1993).
//